Luckily they won't know where the vaccine came from cuz most are ignant. Most will think vaccine came from the US now I guess
.
Last edited:
Coronavirus 2019-2020 thread (no unsubstantiated rumours!)
- Thread starter localizer
- Start date
Luckily they won't know where the vaccine came from cuz most are ignant. Most will think vaccine came from the US now I guess
.
Oh they'll for sure know it's from China, especially if the side effects aren't good. To be honest, it was fortunate that the Chinese didn't offer its vaccines to the Western nations and other aligned nations. Otherwise, the situation would have went fubar. IMO, China should have just kept its mouth shut about its vaccines and play safe by selecting countries that align with its interests under the table. Yes, it would have politicized the vaccine, but lets be real. Everything can and will be politicized when it comes to international relations.Luckily they won't know where the vaccine came from cuz most are ignant. Most will think vaccine came from the US now I guess
Luckily they won't know where the vaccine came from cuz most are ignant. Most will think vaccine came from the US now I guess
Don't know why you guys are worrying. All the complaints about Chinese face masks, PPE, and test kit didn't stop them from importing. Most countries have enrolled volunteers in the clinical trial before granting the emergency use of the vaccine. So whenever there is a problem, their own hospitals or agency that participated and conducted the trial would be equally responsible. Beside China has administered over 1 million participants for emergency vaccinations without dire side effects.
More importantly, those wealthy western nations and countries such as SK or Japan would probably not use Chinese vaccines anyway. For other countries that willing to conduct clinical trial before approving, I think the risk is manageable.
Hendrik_2000
Lieutenant General
It is doing well thank you Here it is 1 million men were vacinated with no complication and none has contracted corona. It does not need super cool storage and can be transported easily I think China has a winner here specially in developing countries where the super duper facilities is not available
Nearly 1 million receive vaccine developed by Sinopharm
By Hu Yuwei and Leng Shumei Source: Global Times Published: 2020/11/19 23:23:40
China’s vaccines are also very effective: head of China’s CD
Advantages of China’s COVID-19 inactivated vaccines in the world vaccine competition Infographic: GT
Chinese vaccine makers said that China's full-throttled development of COVID-19 vaccines remains in the lead among a roster of effective vaccines, although some Western media and politicians have questioned China for delays in releasing late-stage trial data after US drug makers Pfizer and Moderna's successes. The fact is, however, at least three out of five types of Chinese vaccines against the coronavirus have entered final stage trials, with the latest beginning phase-III trials in central China's Hunan Province on Thursday.
China's leading vaccine producer Sinopharm told the Global Times on Thursday that it has reported the phase-III clinical data to China's relevant regulators and is improving the data as requested. The vaccine maker, claiming it is in the final stage before marketing, stressed that it is not under pressure to reveal its vaccine data and will do so in a more scientific and controlled way.
The inactivated vaccines developed by Sinopharm are leading the world in all aspects such as research and development, clinical trials, and production and emergency use status, the head of Sinopharm Liu Jingzhen told the media on Wednesday.
Another leading inactivated vaccine producer, Sinovac, by contrast, has taken a more cautious tone, telling the Global Times on Thursday that it will not release the relevant data until it is assured to obtain enough number of qualified COVID-19 cases in its double-blind, placebo-controlled trials to certify vaccine effectiveness. The release is expected to be announced by the end of November.
US companies Moderna and Pfizer recently disclosed that their vaccines for the coronavirus are able to offer more than 90 percent efficacy, injecting confidence into the global anti-virus fight and raising public expectations on the data release of their Chinese competitors.
However, the speed of data acquisition is largely dependent on the severity of the epidemic situation in host countries and the enrollment schedule of volunteers in partnered institutions, according to analysts and industry insiders.
China has laid out five technical routes to develop the vaccine since the initial outbreak. Five Chinese vaccine candidates are under clinical trials in countries including the UAE, , Pakistan and Peru, and phase-I and II clinical trials of other candidates have been accelerated, Chinese Foreign Ministry Spokesperson Zhao Lijian briefed on Wednesday.
China initiated its first domestic late-stage trials of a COVID-19 recombinant subunit vaccine on Thursday, making it the fifth Chinese-developed candidate to enter final stage clinical trials.
The producer is carrying out trials in countries including Uzbekistan, as some indicators in trials need to be obtained in other countries whereas others are best verified at home, the Global Times learnt from vaccine producer Anhui Zhifei Longcom Biopharmaceutical.
Current data shows that the remaining four Chinese vaccine candidates entering phase-III trials can all elicit a rapid immune response and offer good protection.
Sinopharm's two inactivated vaccines have been administered to nearly one million people for emergency use and no serious adverse reactions have been reported. Nearly 60,000 volunteers have participated in the phase-III clinical trials in more than 10 countries, Liu told media.
Director of the Chinese Center for Disease Control and Prevention (CDC) Gao Fu encouraged Chinese public by saying that China's vaccines are also very effective at an online seminar on Thursday. "Currently, no vaccine has completed phase-III clinical trials, but Pfizer and Moderna have claimed that their vaccines are very effective. Please trust me, I want to tell the public that China's vaccines are also very effective," Gao said.
Many countries have pinned their hopes on Chinese-developed vaccines to stop the pandemic, and countries including , and Indonesia are importing Chinese vaccines currently.
Nevertheless, the World Health Organization's emergencies director warned on Wednesday that vaccines would not arrive in time to defeat the second wave of the COVID-19 pandemic. "It's at least four to six months before we have significant levels of vaccination going on anywhere," said the director.
Rapid release
"Not releasing data does not represent slow progress. Our data is evaluated by relevant departments following strict protocols, and we are in close communication with the WHO," a representative of Sinopharm told the Global Times.
Notably, trial progress largely depends on the outbreak degree and trends in host countries. Given that COVID-19 has continued to surge in the US, it is faster and easier to find the required number of post-vaccination infections in their placebo group to quickly announce the protection rate, said analysts.
"Even if the data are available, it would take time for us to review its eligibility because China's approval authorities differ from the US' in terms of data identification standards," a source close to Sinovac told the Global Times.
"In addition, the progress of a host country's research teams in recruiting volunteers and inoculation arrangements also affects the pace of releasing results," the source said.
It is doing well thank you Here it is 1 million men were vacinated with no complication and none has contracted corona. It does not need super cool storage and can be transported easily I think China has a winner here specially in developing countries where the super duper facilities is not available
Nearly 1 million receive vaccine developed by Sinopharm
By Hu Yuwei and Leng Shumei Source: Global Times Published: 2020/11/19 23:23:40
China’s vaccines are also very effective: head of China’s CD
Advantages of China’s COVID-19 inactivated vaccines in the world vaccine competition Infographic: GT
Chinese vaccine makers said that China's full-throttled development of COVID-19 vaccines remains in the lead among a roster of effective vaccines, although some Western media and politicians have questioned China for delays in releasing late-stage trial data after US drug makers Pfizer and Moderna's successes. The fact is, however, at least three out of five types of Chinese vaccines against the coronavirus have entered final stage trials, with the latest beginning phase-III trials in central China's Hunan Province on Thursday.
China's leading vaccine producer Sinopharm told the Global Times on Thursday that it has reported the phase-III clinical data to China's relevant regulators and is improving the data as requested. The vaccine maker, claiming it is in the final stage before marketing, stressed that it is not under pressure to reveal its vaccine data and will do so in a more scientific and controlled way.
The inactivated vaccines developed by Sinopharm are leading the world in all aspects such as research and development, clinical trials, and production and emergency use status, the head of Sinopharm Liu Jingzhen told the media on Wednesday.
Another leading inactivated vaccine producer, Sinovac, by contrast, has taken a more cautious tone, telling the Global Times on Thursday that it will not release the relevant data until it is assured to obtain enough number of qualified COVID-19 cases in its double-blind, placebo-controlled trials to certify vaccine effectiveness. The release is expected to be announced by the end of November.
US companies Moderna and Pfizer recently disclosed that their vaccines for the coronavirus are able to offer more than 90 percent efficacy, injecting confidence into the global anti-virus fight and raising public expectations on the data release of their Chinese competitors.
However, the speed of data acquisition is largely dependent on the severity of the epidemic situation in host countries and the enrollment schedule of volunteers in partnered institutions, according to analysts and industry insiders.
China has laid out five technical routes to develop the vaccine since the initial outbreak. Five Chinese vaccine candidates are under clinical trials in countries including the UAE, , Pakistan and Peru, and phase-I and II clinical trials of other candidates have been accelerated, Chinese Foreign Ministry Spokesperson Zhao Lijian briefed on Wednesday.
China initiated its first domestic late-stage trials of a COVID-19 recombinant subunit vaccine on Thursday, making it the fifth Chinese-developed candidate to enter final stage clinical trials.
The producer is carrying out trials in countries including Uzbekistan, as some indicators in trials need to be obtained in other countries whereas others are best verified at home, the Global Times learnt from vaccine producer Anhui Zhifei Longcom Biopharmaceutical.
Current data shows that the remaining four Chinese vaccine candidates entering phase-III trials can all elicit a rapid immune response and offer good protection.
Sinopharm's two inactivated vaccines have been administered to nearly one million people for emergency use and no serious adverse reactions have been reported. Nearly 60,000 volunteers have participated in the phase-III clinical trials in more than 10 countries, Liu told media.
Director of the Chinese Center for Disease Control and Prevention (CDC) Gao Fu encouraged Chinese public by saying that China's vaccines are also very effective at an online seminar on Thursday. "Currently, no vaccine has completed phase-III clinical trials, but Pfizer and Moderna have claimed that their vaccines are very effective. Please trust me, I want to tell the public that China's vaccines are also very effective," Gao said.
Many countries have pinned their hopes on Chinese-developed vaccines to stop the pandemic, and countries including , and Indonesia are importing Chinese vaccines currently.
Nevertheless, the World Health Organization's emergencies director warned on Wednesday that vaccines would not arrive in time to defeat the second wave of the COVID-19 pandemic. "It's at least four to six months before we have significant levels of vaccination going on anywhere," said the director.
Rapid release
"Not releasing data does not represent slow progress. Our data is evaluated by relevant departments following strict protocols, and we are in close communication with the WHO," a representative of Sinopharm told the Global Times.
Notably, trial progress largely depends on the outbreak degree and trends in host countries. Given that COVID-19 has continued to surge in the US, it is faster and easier to find the required number of post-vaccination infections in their placebo group to quickly announce the protection rate, said analysts.
"Even if the data are available, it would take time for us to review its eligibility because China's approval authorities differ from the US' in terms of data identification standards," a source close to Sinovac told the Global Times.
"In addition, the progress of a host country's research teams in recruiting volunteers and inoculation arrangements also affects the pace of releasing results," the source said.
Would like to see how many of these people went out and got infected.
I read in another article that 80% of Swiss farmers eat dog/cat meat. Man I'm surprised no one knows about this. Once again, Asians get accused of killing Muslims, which is bizarre when you think about it.
solarz
Brigadier
It seems like the trend is getting clearer: western-aligned nations will be using US vaccines, while the rest of the world will be using Chinese vaccines.
That's assuming the US vaccines work as promised, which is an optimistic assumption.
Western vaccine may not even work though and the process is so None transparent that really, who is going to trust them and whether or not they will slip a micro chip into you. One thing that scares me is that the media in the west will paint themselves as the heroes while they paint China and its allies as the villains. The only problem is the in reality, that actions of the west are far more villainous then that of China and hence we won't be able to see which vaccine is more effective then the other and if so whether there is a choice in what to take since it quite clear that the west doesn't care about safety as opposed to profits
Last edited: